144 related articles for article (PubMed ID: 8212437)
1. Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers.
Storm FK; Mahvi DM; Gilchrist KW
Urology; 1993 Oct; 42(4):379-82. PubMed ID: 8212437
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
3. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
Varma M; Morgan M; Amin MB; Wozniak S; Jasani B
Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749
[TBL] [Abstract][Full Text] [Related]
5. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of heat shock protein-70 expression in bladder cancer.
Syrigos KN; Harrington KJ; Karayiannakis AJ; Sekara E; Chatziyianni E; Syrigou EI; Waxman J
Urology; 2003 Mar; 61(3):677-80. PubMed ID: 12639682
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
[TBL] [Abstract][Full Text] [Related]
8. Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer.
Crow P; Molckovsky A; Stone N; Uff J; Wilson B; WongKeeSong LM
Urology; 2005 Jun; 65(6):1126-30. PubMed ID: 15913721
[TBL] [Abstract][Full Text] [Related]
9. The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder.
Basiri A; Ozhand A; Karami H; Parham HA; Safarinejad MR
J Pak Med Assoc; 2008 Sep; 58(9):479-81. PubMed ID: 18846793
[TBL] [Abstract][Full Text] [Related]
10. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
14. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
Lebret T; Watson RW; Molinié V; O'Neill A; Gabriel C; Fitzpatrick JM; Botto H
Cancer; 2003 Sep; 98(5):970-7. PubMed ID: 12942564
[TBL] [Abstract][Full Text] [Related]
15. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
18. [A case of synchronous double primary cancers of prostate, and bladder in a hemodialysis patient: a case report].
Abe T; Hayashi T; Nakayama J; Kishikawa H; Sekii K; Yoshioka T; Itatani H; Kojima Y; Takahara S
Hinyokika Kiyo; 2005 Oct; 51(10):689-93. PubMed ID: 16285625
[TBL] [Abstract][Full Text] [Related]
19. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.
Patry G; Hovington H; Larue H; Harel F; Fradet Y; Lacombe L
Int J Cancer; 2008 Apr; 122(7):1592-7. PubMed ID: 18058798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
